Skip to main content
Figure 2 | Cardiovascular Ultrasound

Figure 2

From: Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease

Figure 2

Heart rate during study protocol. Values are presented as median (Q1-Q3)..Iva: ivabradine; baseline: difference between heart rate at 08.00 and 12.00 at study visit 1 (without Iva); Iva acute effect: difference between heart rate before and 4 hours after Iva; Iva sustained effect: difference between heart rate before first dose of Iva (study visit 2) and after 4 weeks of Iva intake twice daily (10 to 15 mg). * p < 0.05 for Iva acute effects vs. baseline and Iva sustained effects vs. baseline.

Back to article page